Filtros : "Faintuch, Joel" "EACH-GER-86" "FM" Removidos: "Moffa, Paulo Jorge" "WAJCHENBERG, BERNARDO LEO" Limpar

Filtros



Limitar por data


  • Fonte: Frontiers in Cellular and Infection Microbiology. Unidades: ICB, FM, EACH

    Assuntos: DOENÇAS INFECCIOSAS, BIÓPSIA, DOENÇAS RESPIRATÓRIAS, DOENÇAS INFECCIOSAS, BIOMARCADORES

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BELIZARIO, Jose Ernesto e FAINTUCH, Joel e GARAY-MALPARTIDA, Humberto Miguel. Breath biopsy and discovery of exclusive volatile organic compounds for diagnosis of infectious diseases. Frontiers in Cellular and Infection Microbiology, v. 10, n. Ja 2021, p. 01-13, 2021Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2020.564194. Acesso em: 15 jun. 2024.
    • APA

      Belizario, J. E., Faintuch, J., & Garay-Malpartida, H. M. (2021). Breath biopsy and discovery of exclusive volatile organic compounds for diagnosis of infectious diseases. Frontiers in Cellular and Infection Microbiology, 10( Ja 2021), 01-13. doi:10.3389/fcimb.2020.564194
    • NLM

      Belizario JE, Faintuch J, Garay-Malpartida HM. Breath biopsy and discovery of exclusive volatile organic compounds for diagnosis of infectious diseases [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 10( Ja 2021): 01-13.[citado 2024 jun. 15 ] Available from: https://doi.org/10.3389/fcimb.2020.564194
    • Vancouver

      Belizario JE, Faintuch J, Garay-Malpartida HM. Breath biopsy and discovery of exclusive volatile organic compounds for diagnosis of infectious diseases [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 10( Ja 2021): 01-13.[citado 2024 jun. 15 ] Available from: https://doi.org/10.3389/fcimb.2020.564194
  • Fonte: Mediators of Inflammation. Unidades: FM, EACH

    Assunto: DOENÇAS METABÓLICAS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BELIZARIO, Jose Ernesto e FAINTUCH, Joel e GARAY-MALPARTIDA, Humberto Miguel. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators of Inflammation, v. 2018, p. 01-12, 2018Tradução . . Disponível em: https://doi.org/10.1155/2018/2037838. Acesso em: 15 jun. 2024.
    • APA

      Belizario, J. E., Faintuch, J., & Garay-Malpartida, H. M. (2018). Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators of Inflammation, 2018, 01-12. doi:10.1155/2018/2037838
    • NLM

      Belizario JE, Faintuch J, Garay-Malpartida HM. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases [Internet]. Mediators of Inflammation. 2018 ; 2018 01-12.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1155/2018/2037838
    • Vancouver

      Belizario JE, Faintuch J, Garay-Malpartida HM. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases [Internet]. Mediators of Inflammation. 2018 ; 2018 01-12.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1155/2018/2037838

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024